Dr med. Margarete Kern
Senior physician
Specialist in internal medicine, rheumatology
Further information about Dr. med.
| 12/97 | State examination |
| until 10/98 | Further training Neurology at the ZKH Reinkenheide, Bremerhaven |
| until 03/01 | Further training Internal Medicine at the DRK Hospital Rissen, Hamburg |
| until 09/07 | Further training and work as a specialist in internal medicine at Ev. Amalie-Sieveking KH, Hamburg |
| until 04/11 | Further training and work as a specialist for internal medicine and rheumatology at the Rheumaklinik Bad Bramstedt, University Hospital Schleswig-Holstein (UKSH) |
| until 12/13 | Senior physician at the Clinic for Rheumatology, Clinical Immunology and Nephrology, Asklepios Klinik Altona, Hamburg, Chief Physician: Dr. K. Ahmadi-Simab. Establishment of §116b rheumatology outpatient clinic and study outpatient clinic, hygiene and QM representative |
| since 01/14 | Senior physician at MEDIZINICUM Hamburg |
- Specialist for internal medicine
- Specialist in rheumatology
- Specialisation in internal medicine X-ray diagnostics
- Hygiene Officer Doctor
- Investigator for clinical studies
- DEGUM Certificate Arthrosonography
Supervision of the following studies:
- RABBIT/RABBIT 2: Long-term monitoring of the efficacy and tolerability of a therapy with biologics in patients with rheumatoid arthritis compared to conventional basic therapy
- ReAlise: Application monitoring according to ReAct (Adalimumab); Title: "A Five-year, Post-marketing Observational Study to Follow-up Patients With Rheumatoid Arthritis Formerly Treated in Study M02-497 (ReAct) and Subsequently Prescribed Humira".
- MHE 100901: Open Label Study with Mepolizumab (IL5-Ak) in Hypereosinophilic Syndrome; Title: "An Open-Label Extension Study to Study MHE100185, to Evaluate Long-term Safety, Efficacy and Optimal Dosing Frequency of 750 mg Intravenous Mepolizumab in Subjects With Hypereosinophilic Syndromes".
- WA 18695: Open label study according to WA 17822 with tocilizumab in RA; Title: "Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in WA17822".
- CERTAIN: Phase IIIB, double-blind, placebo-controlled, multicenter study with certolizumab and stable DMARD therapy in RA
- MUSE: Comparison between MASES and UltraSchall in the follow-up study of Enthesitis in a cohort of AS and PsA Patients
- WA 27788: Phase II/III, double-blind, placebo-controlled multicenter study on efficacy, efficacy and safety of tocilizumab versus placebo in systemic sclerosis patients
- DUAL2: Study on macitentan in patients with digital ulcers in systemic sclerosis; Title: "Prospective, Randomized, Placebo-controlled, Double-blind, Mutlicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Patients With Schemic Digital Ulcers Associated With Systemic Sclerosis".
- German Society for Internal Medicine
- German Society for Rheumatology
- Association of German Rheumatologists
Internal Medicine and Rheumatology at Semmelweis University, Asklepios Campus Hamburg.
Publication
- M. Kern, K. Ahmadi-Simab: Recurrent polychondritis; arthritis + rheumatism 4/2013, 251-255
Lectures
- for patients (seminars, Hamburg Scleroderma Patients' Day, World Rheumatism Day): vasculitis, collagenosis, arthritis, medication, diagnostic methods
- for physicians (public lectures): arthrosonography, early diagnosis of rheumatoid arthritis, diagnosis of rheumatological systemic diseases, organ involvement in rheumatological diseases, pitfalls in immunodeficiency assessment, fever in rheumatology
All inflammatory rheumatic systemic diseases
Chronic inflammation of joints and spine:
- Rheumatoid arthritis
- Seropositive Rheumatoid Arthritis
- Seronegative Rheumatoid Arthritis
- Spondyloarthritides
- Psoriasis arthritis (arthritis psoriatica)
- Bekhterev's disease /ankylotic spondylitis
- Spondylarthritis in chronic inflammatory bowel diseases (ulcerative colitis, Crohn's disease)
- Infectious arthritides (reactive arthritides)
- Arthritis in other underlying diseases, e.g. metabolic diseases
- Gout, or other crystal arthropathies
- Hemochromatosis
- Sarcoidosis
- Thyroid dysfunction
Collagenoses (connective tissue diseases):
- Systemic lupus erythematosus
- Scleroderma/systemic sclerosis
- Polymyositis/Dermatomyositis
- Sjögren's syndrome
- Mixed collagenoses
- Vasculopathy in collagenosis
- Pulmonary arterial hypertension (pulmonary hypertension)
- Digital ulcers (acral circulatory disorders)
- Vasculitis (inflammation of blood vessels)
| Large vessel vasculitis: | Giant cell arteritis (RZA) Takayasu arteritis (TA) |
| Vasculitis of medium vessels | Polyarteritis nodosa (PAN) Kawasaki disease |
| Small vessel vasculitis | ANCA-associated vasculitis (AAV) Granulomatosis with polyangiitis (GPA, Wegener) Eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss) Microscopic polyangiitis (MPA) |
| Vasculitis of variable vessel sizes | Behçet's disease (BD) Cogan syndrome (CS) |
| Vasculitis of individual organs | Primary angiitis of the CNS (PACNS) Cutaneous leukocytoclastic angiitis (CLA) |
| Vasculitis in systemic disease | Rheumatoid Vasculitis |
| Vasculitis with probable etiology | Vasculitis in collagenosis, in sarcoidosis |
Further clinical pictures:
- immunodeficiency syndromes
- Adult Still Syndrome
- Hereditary Periodic Fever Syndromes (HPF)
- Hypereosinophilic syndrome
- Raynaud's syndrome
- Sarcoidosis
- Thrombangiitis obliterans
- Livedovasculopathy
- Uveitis-associated diseases
- Lyme disease
- osteoporosis
- Diagnostics of all inflammatory rheumatic systemic diseases, common immunodeficiency syndromes and general internal diseases
- Organ screening for autoimmune diseases
- Intra-articular injections of all joints and diagnostic joint punctures
- Capillary microscopy
- Arthrosonography
- Abdominal sonography
- Sonography of thyroid gland, vessels
- Echocardiography
- Cerebrospinal fluid puncture
- Bone marrow puncture
- Puncture of pleural effusion or ascites
